239 related articles for article (PubMed ID: 6227332)
21. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
22. Preparation of monoclonal antibodies against glycoprotein IIIa of human platelets. Their effect on platelet aggregation.
Melero JA; Gonzalez-Rodriguez J
Eur J Biochem; 1984 Jun; 141(2):421-7. PubMed ID: 6203747
[TBL] [Abstract][Full Text] [Related]
23. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
[TBL] [Abstract][Full Text] [Related]
24. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a monoclonal antibody ITI-Pl 1 directed against human platelet membrane glycoprotein IIb using extracts of whole platelets and platelet surface and intracellular membranes.
Thorsen LI; Gaudernack G; Hack N; Wilkinson JM; Brosstad F; Solum NO; Crawford N
Br J Haematol; 1988 Jan; 68(1):67-74. PubMed ID: 3278733
[TBL] [Abstract][Full Text] [Related]
26. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation.
Niiya K; Hodson E; Bader R; Byers-Ward V; Koziol JA; Plow EF; Ruggeri ZM
Blood; 1987 Aug; 70(2):475-83. PubMed ID: 3607284
[TBL] [Abstract][Full Text] [Related]
27. Production and characterization of monoclonal antibodies against rat platelet GPIIb/IIIa.
Miyazaki H; Tamura S; Sudo T; Suzuki T
Thromb Res; 1990 Sep; 59(6):941-53. PubMed ID: 2264020
[TBL] [Abstract][Full Text] [Related]
28. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123).
Kornecki E; Lee H; Merlin F; Hershock D; Tuszynski GP; Niewiarowski S
Thromb Res; 1984 Apr; 34(1):35-49. PubMed ID: 6328693
[TBL] [Abstract][Full Text] [Related]
29. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
[TBL] [Abstract][Full Text] [Related]
31. Detection of glycoprotein IIb and IIIa by monoclonal antibodies.
Thurlow PJ; Barlow B; Connellan JM; McKenzie IF
Br J Haematol; 1983 Sep; 55(1):123-34. PubMed ID: 6224505
[TBL] [Abstract][Full Text] [Related]
32. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies.
Ginsberg MH; Frelinger AL; Lam SC; Forsyth J; McMillan R; Plow EF; Shattil SJ
Blood; 1990 Nov; 76(10):2017-23. PubMed ID: 2242424
[TBL] [Abstract][Full Text] [Related]
33. PL2-49, a monoclonal antibody against glycoprotein IIb which is a platelet activator.
Morel MC; Lecompte T; Champeix P; Favier R; Potevin F; Samama M; Salmon C; Kaplan C
Br J Haematol; 1989 Jan; 71(1):57-63. PubMed ID: 2917129
[TBL] [Abstract][Full Text] [Related]
34. An antiplatelet monoclonal antibody that inhibits ADP and epinephrine-induced aggregation.
Vilella R; Lozano T; Mila J; Borche L; Ercilla G; Ordinas T; Vives J
Thromb Haemost; 1984 Feb; 51(1):93-6. PubMed ID: 6232732
[TBL] [Abstract][Full Text] [Related]
35. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
36. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex].
Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV
Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408
[TBL] [Abstract][Full Text] [Related]
38. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
[TBL] [Abstract][Full Text] [Related]
39. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.
Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF
J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen fragments and platelet dysfunction in uremia.
Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
